Group 1: IPO Market Activity - The Hong Kong IPO market has seen a surge in diverse companies, including leaders in digital healthcare and lidar technology, with significant activity from sectors like prefabricated steel structures and photovoltaic cells [2][3] - Health160, China's largest digital healthcare service platform, saw its stock price soar by 137.34% on its debut, covering over 260 cities and connecting 44,600 medical institutions [6] - Hesai Technology, a leader in the lidar sector, achieved a dual listing on both US and Hong Kong exchanges, with a market capitalization exceeding HKD 36 billion on its first day [7][8] Group 2: Companies Approved for IPO - Yuan Chuang Technology has received approval for its mainboard IPO, focusing on the research, production, and sales of rubber tracks for agricultural and engineering machinery, with projected revenues of CNY 1.261 billion in 2022 [4] - New Guangyi, a high-tech enterprise specializing in high-performance functional materials, also received approval for its IPO, with revenues expected to grow from CNY 455 million in 2022 to CNY 657 million in 2024 [5] Group 3: New Listings - Jinfang Pharmaceutical made its debut on the Hong Kong Stock Exchange, with an opening surge of 115.79%, focusing on innovative therapies for tumors and autoimmune diseases [9] - Meilian Steel Structure, a prefabricated steel structure service provider, has refiled for an IPO, reporting a revenue increase of 180% year-on-year for the first half of 2025 [10][11] Group 4: Upcoming IPOs - Zijin Gold International plans to raise approximately USD 3.2 billion through its IPO, potentially becoming the largest IPO since May, coinciding with record-high gold prices [17][18] - Huakin Technology, a leading smart product platform, has submitted its IPO application, reporting a revenue increase of 113.06% year-on-year for the first half of 2025 [12]
数字龙头齐聚港交所 2家净利过亿过会丨IPO一周要闻